Bloomberg Stock Movers
2026-05-12 · Hosted by — · Bloomberg / iHeartMedia
Executive Summary
Bloomberg Stock Movers covered three earnings and M&A stories on May 12: Under Armour missed on sales and profit with a turnaround still in progress; Wendy’s surged ~12% on a Financial Times report that Nelson Peltz’s Trian Fund is seeking investor backing to take the burger chain private; and Hims & Hers fell ~16% after missing Q1 estimates as its pivot to branded GLP-1 drugs compressed margins.
Key Stories & Changes
1. Under Armour — Turnaround Work in Progress
Under Armour (UA): stock was up ~22% ahead of this report; now under pressure post-earnings
Annual revenue expected to decline — Wall Street was looking for a 2% gain
Adjusted EPS also missed estimates
Middle East war adds $35 million in additional costs this year from supply chain impacts
Also affected by tariffs and the split from basketball star Steph Curry
Panel: “Is Under Armour cool?” — branded athletic apparel is extraordinarily competitive; Adidas signing Bad Bunny and Timothée Chalamet for World Cup campaign; brand ambassador race intensifying
2. Wendy’s — Takeover Bid Speculation
Wendy’s (WEN) shares +~12% on the FT report
Nelson Peltz’s Trian Fund Management (owns 16% of Wendy’s) seeking outside investor backing — including from Middle East investors — to take the chain private
Trian has been involved with Wendy’s since 2005 as activist investors; two board seats (one held by Peltz’s son)
Wendy’s shares down more than 40% over the past year; down 71% over five years
Current market value: ~$5 billion
Last week: Wendy’s reported weak quarterly sales, citing high beef costs
No confirmed deal — report indicates early-stage talks with potential co-investors
3. Hims & Hers — GLP-1 Pivot Pain
Hims & Hers (HIMS): Q1 revenue $608 million vs. estimate ~$617 million — a miss
Stock down ~16%; previously reported revenue miss is consistent with prior evening’s CNBC Closing Bell coverage
Gross margins compressed as company shifts from compounded/generic GLP-1s to branded Novo Nordisk weight-loss drugs
Higher costs associated with the pivot acknowledged; company said this is short-term pain
Adjusted EBITDA guidance trimmed (per prior reporting: new range $275–$350M vs. prior $300–$375M)
Trends Identified
1. Consumer Brand Competition is Existential
Under Armour’s struggles reflect a broader truth: in athletic apparel, being “second tier” in brand cachet is nearly fatal. With Nike, Adidas (now aggressively signing pop-culture icons for the World Cup), and Lululemon occupying the brand podium positions, Under Armour lacks a clear identity. Losing Steph Curry — at the peak of his cultural relevance — removed its most distinctive endorsement asset. The tariff headwind adds a cost layer to an already margin-thin business.
2. Private Equity Sees Value in Beaten-Down Consumer Brands
Wendy’s down 71% over five years represents classic value-investor territory — a recognizable brand, franchise cash flows, and a dramatically lower share price creating potential PE return math. Trian’s willingness to seek Middle East co-investment signals confidence in the underlying franchise cash flow story, even if the public market has abandoned the stock. The move also echoes the broader theme of PE moving into consumer brands that public markets have punished.
3. GLP-1 Regulatory Compliance Has a Margin Price
Hims & Hers’ pivot away from compounded GLP-1s was involuntary — regulators and pharma companies forced it. The margin compression is the cost of compliance. The question for investors is whether the company’s customer retention through this transition and its new branded relationships with Novo Nordisk will restore margins faster than the market expects. —-
Sentiment Analysis
Overall Market Sentiment: Mixed — Consumer/Brand Stress
Short segment focused on earnings misses and M&A speculation. All three stories reflect consumer sector stress in different forms — execution failures, depressed valuations attracting private equity, and regulatory-driven business model pivots.
Risk Factors Highlighted
Under Armour brand irrelevance: Losing Steph Curry without a comparable replacement in a hyper-competitive branded athletic market is a structural risk, not a cyclical one
Middle East war supply chain costs: UA quantified $35 million in additional costs — illustrates direct corporate P&L impact of Strait of Hormuz disruption
Tariff impact on athletic goods: Supply chain costs compounding brand challenges at Under Armour
Wendy’s deal uncertainty: Trian seeking co-investment suggests they lack capital to proceed alone; deal may not close
Hims & Hers customer attrition during pivot: GLP-1 customers who started on compounded products may not follow to more expensive branded alternatives
Consumer spending environment: All three companies operate in discretionary/consumer-facing segments experiencing broader macro headwinds
This episode was covered in today’s The Market Signal — 2026-05-12, a cross-source synthesis of multiple podcast reports.